Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.

Journal Article (Journal Article)

[Figure: see text].

Full Text

Duke Authors

Cited Authors

  • Kirtane, AJ; Stoler, R; Feldman, R; Neumann, F-J; Boutis, L; Tahirkheli, N; Toelg, R; Othman, I; Stein, B; Choi, JW; Windecker, S; Yeh, RW; Dauerman, HL; Price, MJ; Underwood, P; Allocco, D; Meredith, I; Kereiakes, DJ

Published Date

  • March 2021

Published In

Volume / Issue

  • 14 / 3

Start / End Page

  • e010144 -

PubMed ID

  • 33641374

Electronic International Standard Serial Number (EISSN)

  • 1941-7632

Digital Object Identifier (DOI)

  • 10.1161/CIRCINTERVENTIONS.120.010144


  • eng

Conference Location

  • United States